| Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis Y Zhou, S Huang, Y Guo, M Ran, W Shan, WH Chen, KY Tam Phytotherapy Research 37 (12), 5837-5853, 2023 | 12 | 2023 |
| Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing Y Zhou, Y Guo, M Ran, W Shan, C Granchi, E Giovannetti, F Minutolo, ... Cancer Letters 577, 216425, 2023 | 12 | 2023 |
| Dichloroacetophenone biphenylsulfone ethers as anticancer pyruvate dehydrogenase kinase inhibitors in non-small cell lung cancer models Y Guo, Y Zhou, P Wu, M Ran, N Xu, W Shan, O Sha, KY Tam Chemico-Biological Interactions 378, 110467, 2023 | 6 | 2023 |
| Cytosolic malic enzyme and glucose‐6‐phosphate dehydrogenase modulate redox balance in NSCLC with acquired drug resistance M Ran, Y Zhou, Y Guo, D Huang, SL Zhang, KY Tam The FEBS Journal 290 (19), 4792-4809, 2023 | 4 | 2023 |
| Targeting hexokinase 2 to enhance anticancer efficacy of trichosanthin in HeLa and SCC25 cell models Y Zhou, M Ran, W Shan, K Wang, O Sha, KY Tam ADMET and DMPK 12 (6), 821-841, 2024 | | 2024 |
| Targeting hexokinase 2 to enhance anticancer efficacy of trichosanthin in HeLa and SCC25 cell models: Original scientific article K Tam, M Ran, W Shan, K Wang, O Sha, Y Zhou ADMET and DMPK 12 (6), 821-841, 2024 | | 2024 |
| Exploring casual effects and shared molecular mechanism between psoriasis and liver cancer through Mendelian randomization and comprehensive bioinformatic analyses M Ran, O Sha, KY Tam Computational Biology and Chemistry 110, 108089, 2024 | | 2024 |
